Master in Health Biotechnology

Tuition fees for Master in Health Biotechnology are 1,000 EUR per year.

Health Biotechnology is a master's degree offered in English at Università della Calabria, based on its campus in Arcavacata di Rende, in the Calabria region of southern Italy, over a two-year course of study. Health biotechnology applies biological and biomedical science to the development of tools, therapies and diagnostics used in human health, drawing on molecular biology, genetics, immunology and biochemistry. Students in this field typically study cell and molecular biology, genetic engineering techniques, immunology, and the methods used to develop diagnostic tests, vaccines and therapeutic products, often combined with laboratory-based practical training. Coursework may also extend into areas such as regenerative medicine, genomics, bioinformatics, or the regulatory processes that govern how biomedical products move from research into clinical and commercial use. Because health biotechnology sits at the interface of biology, medicine and industry, graduates are prepared for roles in biomedical and pharmaceutical research, diagnostics companies, quality control and regulatory affairs, as well as academic and clinical research laboratories. Some continue into doctoral study, particularly for those aiming toward careers in biomedical research or drug and diagnostic development. The program requires a bachelor's degree or equivalent qualification for admission, along with success in an entrance examination. Studying this master's degree in English at Università della Calabria allows international students to build on undergraduate training in the life sciences while gaining more specialized knowledge connected to human health, based at the university's campus in Arcavacata di Rende in southern Italy.